CytomX Therapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2017 | — | -81.8% | -76.2% |
| FY2018 | — | -132.0% | -143.4% |
| FY2019 | — | -360.3% | -338.3% |
| FY2020 | — | -80.1% | -64.5% |
| FY2021 | — | -164.6% | -164.4% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2017 | — | -81.8% | -76.2% |
| FY2018 | — | -132.0% | -143.4% |
| FY2019 | — | -360.3% | -338.3% |
| FY2020 | — | -80.1% | -64.5% |
| FY2021 | — | -164.6% | -164.4% |